Home » Stocks » SCPS

Scopus Biopharma, Inc. (SCPS)

Stock Price: $13.21 USD 0.24 (1.85%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $13.89 +0.68 (5.15%) Jan 15, 7:59 PM
Market Cap 197.83M
Revenue (ttm) n/a
Net Income (ttm) -10.41M
Shares Out 12.68M
EPS (ttm) -0.82
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $13.21
Previous Close $12.97
Change ($) 0.24
Change (%) 1.85%
Day's Open 13.10
Day's Range 12.96 - 13.50
Day's Volume 69,176
52-Week Range 5.92 - 33.96


Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 3 weeks ago

NEW YORK, Dec. 29, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the appointment of additional members to its Board of Directors. Scopus is a biopharmaceutical comp...

PRNewsWire - 1 month ago

NEW YORK, Dec. 18, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the closing of its initial public offering. The underwriters for the initial public offering exerci...

InvestorPlace - 1 month ago

Scopus BioPharma (SCPS) stock is soaring higher as the company's IPO continues on Thursday and InvestorPlace has all the details. The post SCPS Stock: 14 Things to Know About the Scopus BioPha...

Benzinga - 1 month ago

Scopus Biopharma Inc (NASDAQ: SCPS) shares, which debuted on the Nasdaq Wednesday, are ripping higher. What Happened: New York-based Scopus, a biopharma company developing therapeutics for ser...

Market Watch - 1 month ago

Shares of Oriental Culture Holding Ltd. more than tripled (up 204.3%) in premarket trading Thursday, as the Hong Kong-based provider of collectibles and artwork e-commerce services heads for i...

PRNewsWire - 1 month ago

NEW YORK, Dec. 15, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the pricing of its initial public offering. The company's common stock is set to begin trading Wedn...

About SCPS

Scopus Biopharma is a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. To achieve our mission, we seek to capitalize on ground-breaking scientific and medical discoveries at some of the world’s foremost academic and research institutions. Our strategic partners, City of Hope, NIH and Hebrew University and their respective scientists, medical doctors and other senior researchers with whom we are working at each of our strategic partners are leaders in their resp... [Read more...]

IPO Date
Dec 16, 2020
Morris C. Laster, M.D.
Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

Financial Statements